Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection (Q46232144)

20 December 2017

title

Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection (English)

1 reference

20 December 2017

author

Frederick M. Hecht

4

1 reference

20 December 2017

author name string

B Martinez-Mariño

1

1 reference

20 December 2017

B M Ashlock

2

1 reference

20 December 2017

S Shiboski

3

1 reference

20 December 2017

J A Levy

5

1 reference

20 December 2017

publication date

1 March 2004

1 reference

20 December 2017

Journal of Clinical Immunology

published in

1 reference

20 December 2017

volume

24

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

135-144

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1023/b:joci.0000019778.96564.26

exact match

0 references

cites work

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

12 December 2020

Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Use of laboratory tests and clinical symptoms for identification of primary HIV infection

1 reference

12 December 2020

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

1 reference

12 December 2020

Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression

1 reference

12 December 2020

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons

1 reference

12 December 2020

Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection

1 reference

12 December 2020

Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection

1 reference

12 December 2020

Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection

1 reference

12 December 2020

Role of beta-chemokines in suppressing HIV replication

1 reference

12 December 2020

Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection

1 reference

12 December 2020

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

12 December 2020

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

1 reference

12 December 2020

Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality

1 reference

12 December 2020

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial

1 reference

12 December 2020

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

12 December 2020

HIV pathogenesis and long-term survival

1 reference

12 December 2020

Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection

1 reference

12 December 2020

Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

1 reference

12 December 2020

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

12 December 2020

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses

1 reference

12 December 2020

HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication

1 reference

12 December 2020

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection

1 reference

12 December 2020

The IL-2/IL-2 receptor system: a target for rational immune intervention

1 reference

12 December 2020

Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial

1 reference

12 December 2020

Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s

1 reference

12 December 2020

Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission

1 reference

12 December 2020

Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.

1 reference

12 December 2020

Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.

1 reference

12 December 2020

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual

1 reference

12 December 2020

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

1 reference

12 December 2020

Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART

1 reference

12 December 2020

Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells

1 reference

12 December 2020

Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.

1 reference

12 December 2020

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

12 December 2020

Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2

1 reference

12 December 2020

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia.

1 reference

12 December 2020

The importance of the innate immune system in controlling HIV infection and disease

1 reference

12 December 2020

Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy

1 reference

12 December 2020

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions

1 reference

12 December 2020

Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease

1 reference

12 December 2020

Acute activation of CD8+ T lymphocytes in interleukin-2-treated HIV-infected patients. ANRS-048 IL-2 Study Group. Agence Nationale de Recherches sur le SIDA

1 reference

12 December 2020

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

12 December 2020

10.1023/B:JOCI.0000019778.96564.26

Identifiers

DOI

1 reference

20 December 2017

Dimensions Publication ID

1019006203

0 references

Fatcat ID

release_m3iqmf65l5ey5drexmlf7eveoy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m3iqmf65l5ey5drexmlf7eveoy

24 November 2022

mapped directly with Wikidata item

PubMed ID

15024180

1 reference

20 December 2017